All news

Director Christoph Ziegler Acquires 30,000 Veraxa Biotech Shares at

Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash

Director Christoph Samuel Ziegler recently purchased 30,000 ordinary shares of Veraxa Biotech AG (NASDAQ:VRXA) at

Read original source

VRXA company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.